Intellia Therapeutics Inc (NTLA) — Cash Flow Reinvestment Rate
Intellia Therapeutics Inc (NTLA) has a Cash Flow Reinvestment Rate of 1.66x as of June 2020, reinvesting $95.03 Million (capex $1.04 Million plus investments $94.00 Million) from operating cash flow of $57.42 Million. See cash generation quality of Intellia Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Intellia Therapeutics Inc Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Intellia Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Intellia Therapeutics Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Intellia Therapeutics Inc (2016–2016)
Year-by-year capital reinvestment analysis for Intellia Therapeutics Inc. See Intellia Therapeutics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.34x | $12.33 Million | $36.11 Million | $6.17 Million | — |